A significant number of pediatric inflammatory bowel disease patients are exposed to a medication not approved by the Food and Drug Administration for pediatric use
A significant number of pediatric IBD patients were exposed to medication not approved by the FDA for pediatrics. There is an urgent need for more rapid approval of medications for IBD in pediatrics.
Authors
- Courtney Rusch
- Steven J. Steiner (ORCID: https://orcid.org/0000-0002-7461-3905)
- Anthony J. Perkins (ORCID: https://orcid.org/0000-0003-1278-5397)
Institutions
- Riley Hospital for Children (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1002/jpn3.70200
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00